CD34 and acute myeloid leukemia: After 48 hours, we observed that AML, in both direct or Transwell conditions, increased the retention of CTV among CD34+ cells, indicating that both contact and secreted factors from altered MSCs inhibited HSPC proliferation (Figure 2G).